Victoria A. Komater
Abbott Fund(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Mast cells and histamine, Olfactory and Sensory Function Studies, Asthma and respiratory diseases, Neurotransmitter Receptor Influence on Behavior
Most-Cited Works
- → Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist(2005)261 cited
- → Effects of histamine H3 receptor antagonists in two models of spatial learning(2004)70 cited
- → A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats(2005)69 cited
- → Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan(2003)68 cited
- → H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization(2003)58 cited
- → Potentiation of analgesic efficacy but not side effects: Co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats(2011)51 cited
- → ABT-963 [2-(3,4-Difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2 H-pyridazin-3-one], A Highly Potent and Selective Disubstituted Pyridazinone Cyclooxgenase-2 Inhibitor(2004)45 cited
- → Synthesis, Potency, and In Vivo Profiles of Quinoline Containing Histamine H3Receptor Inverse Agonists(2007)29 cited
- → Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: In vitro properties, drug-likeness, and behavioral activity(2007)27 cited
- → Effect of mast cell deficiency and leukotriene inhibition on the influx of eosinophils induced by eotaxin(1997)20 cited